New delivery method for liver cancer radiation therapy
Part of Cancer clinical trials.
This trial tests a special catheter (TriNav) to deliver radiation directly to liver tumors. It aims to improve targeting and reduce side effects for people with liver cancer that cannot be surgically removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with liver cancer that cannot be surgically removed
- Your cancer has spread from another part of the body or started in the liver
- You are eligible for a type of internal radiation therapy called Y90-radioembolization
- You can care for yourself (ECOG score 0-2) and are expected to live at least 3 months
- You have at least one liver tumor that is 1.2 inches (3 cm) or larger
- You do not have tumors that grow in a scattered, infiltrative pattern
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of delivering radiation therapy (Y-90) directly to liver tumors. It aims to see if a special catheter that blocks blood flow (balloon catheter) can deliver the radiation more effectively and safely than the standard method.
This trial tests a radiation treatment called Y-90 given before liver surgery for colorectal cancer that has spread to the liver. The goal is to help the liver grow enough for safer, curative surgery, either right away or as part of a two-step operation.
This study tests a targeted radiation treatment called Y90 for liver tumors that are too large for standard approaches. It aims to see how well the treatment works for people with primary or secondary liver cancers that mainly affect the liver and have at least one tumor bigger than 5 cm.
This study tests whether a targeted radiation treatment called Y-90 segmentectomy can shrink liver tumors. It is for people with one to three small liver tumors that cannot be removed by surgery or destroyed by heat or cold (ablation).
This trial tests a treatment called yttrium-90 carbon microsphere radioembolization for people with liver cancer that has been previously treated. Tiny radioactive beads are delivered directly to the tumor through the blood vessels to destroy cancer cells from inside. This may be an option if your liver cancer has not spread beyond the liver and you can tolerate the procedure.
This trial tests a combination of treatments for liver cancer that cannot be removed by surgery. It uses a special radiation therapy called Y90 along with other drugs to see if they work better together.
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.